Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03467919 · ClinicalTrials.gov registry record · Phase 3

The Effect of Micro Fragmented Adipose Tissue (MFAT) on Knee Osteoarthritis

A Phase 3 study, sponsored by Stanford University.

Completed
Registry status
Phase 3
Development phase
40
Enrollment target

NCT03467919: Completed Phase 3 study, sponsored by Stanford University.

NCT03467919 is a Phase 3 study that has completed, run by Stanford University. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03467919, a Phase 3 study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
Phase 3
Development phase
40 participants
Enrollment target

Study Summary

This is a non-surgical trial comparing the clinical and functional outcomes of patients with osteoarthritis treated with Intra-articular injection of Micro Fragmented Adipose Tissue versus conventional therapy of intra-articular injection of corticosteroid.

Interventions

  • BIOLOGICAL Micro Fragmented Adipose Tissue
  • BIOLOGICAL Corticosteroid injection

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-04-01
Est. Completion 2024-10-29
Phase Phase 3

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT03467919

The ClinicalTrials.gov registry entry for NCT03467919 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Micro Fragmented Adipose Tissue is the first listed.

NCT03467919 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03467919 about?

NCT03467919 is a clinical study titled "The Effect of Micro Fragmented Adipose Tissue (MFAT) on Knee Osteoarthritis". This is a non-surgical trial comparing the clinical and functional outcomes of patients with osteoarthritis treated with Intra-articular injection of Micro Fragmented Adipose Tissue versus conventional therapy of intra-articular injection of corticosteroid.

What is the current status of trial NCT03467919?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 2018-04-01. Estimated completion is 2024-10-29.

What interventions are being tested in trial NCT03467919?

The interventions under investigation include: Micro Fragmented Adipose Tissue (BIOLOGICAL), Corticosteroid injection (BIOLOGICAL).

Who is sponsoring clinical trial NCT03467919?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.